The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125373871 12537387 1 I 20160623 20160707 20160707 EXP NL-JNJFOC-20160701917 JANSSEN AALST JV, TEERNSTRA O, WEBER W, RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REP JOURNAL 2016;9:117-120. 63.00 YR A F Y 0.00000 20160707 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125373871 12537387 1 PS DUROGESIC FENTANYL 1 Transdermal Y N 19813 UNSPECIFIED
125373871 12537387 2 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown Y 0 300 MG UNSPECIFIED QID
125373871 12537387 3 SS MORPHINE MORPHINE 1 Intrathecal Y 0 3.5 MG UNSPECIFIED
125373871 12537387 4 SS MORPHINE MORPHINE 1 Intrathecal Y 0 .5 MG UNSPECIFIED
125373871 12537387 5 SS AMOXICILLIN+CLAVULANIC ACID AMOXICILLINCLAVULANIC ACID 1 Unknown Y 0 UNSPECIFIED
125373871 12537387 6 SS CLONIDINE. CLONIDINE 1 Oral Y 0 .15 MG UNSPECIFIED TID
125373871 12537387 7 SS AMITRIPTYLINE AMITRIPTYLINE 1 Unknown Y 0 25 MG UNSPECIFIED QD
125373871 12537387 8 SS AMITRIPTYLINE AMITRIPTYLINE 1 Unknown Y 0 10 MG UNSPECIFIED
125373871 12537387 9 SS DIAZEPAM. DIAZEPAM 1 Oral Y 0 5 MG UNSPECIFIED TID
125373871 12537387 10 SS AMOXICILLIN+CLAVULANIC ACID AMOXICILLINCLAVULANIC ACID 1 Intravenous (not otherwise specified) Y 0 UNSPECIFIED
125373871 12537387 11 SS OXYCODONE OXYCODONE 1 Oral Y 0 20 MG UNSPECIFIED QID
125373871 12537387 12 C PROPOFOL. PROPOFOL 1 Unknown 0 UNSPECIFIED
125373871 12537387 13 C ROCURONIUM ROCURONIUM BROMIDE 1 Unknown 0 UNSPECIFIED
125373871 12537387 14 C SEVOFLURANE. SEVOFLURANE 1 Unknown 0 UNSPECIFIED
125373871 12537387 15 C SUFENTANIL CITRATE. SUFENTANIL CITRATE 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125373871 12537387 1 Pain
125373871 12537387 2 Product used for unknown indication
125373871 12537387 3 Amputation stump pain
125373871 12537387 4 Amputation stump pain
125373871 12537387 5 Product used for unknown indication
125373871 12537387 6 Pain
125373871 12537387 7 Amputation stump pain
125373871 12537387 8 Amputation stump pain
125373871 12537387 9 Muscle spasms
125373871 12537387 10 Local anaesthesia
125373871 12537387 11 Pain
125373871 12537387 12 General anaesthesia
125373871 12537387 13 General anaesthesia
125373871 12537387 14 General anaesthesia
125373871 12537387 15 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125373871 12537387 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125373871 12537387 Hemiparesis
125373871 12537387 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found